| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A standardized approach to the evaluation of antivirals against DNA viruses: Orthopox-, adeno-, and herpesviruses
|
Hartline, Caroll B.
|
|
2018
|
159 |
C |
p. 104-112
|
article
|
| 2 |
A standardized approach to the evaluation of antivirals against DNA viruses: Polyomaviruses and lymphotropic herpesviruses
|
Keith, Kathy A.
|
|
2018
|
159 |
C |
p. 122-129
|
article
|
| 3 |
Comparison of early and recent influenza A(H1N1)pdm09 isolates harboring or not the H275Y neuraminidase mutation, in vitro and in animal models
|
Abed, Yacine
|
|
2018
|
159 |
C |
p. 26-34
|
article
|
| 4 |
CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging
|
Wu, Shuo
|
|
2018
|
159 |
C |
p. 1-12
|
article
|
| 5 |
Editorial Board
|
|
|
2018
|
159 |
C |
p. ii
|
article
|
| 6 |
Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney disease
|
Ogawa, Eiichi
|
|
2018
|
159 |
C |
p. 143-152
|
article
|
| 7 |
Fluoxetine can inhibit coxsackievirus-B4 E2 in vitro and in vivo
|
Benkahla, Mehdi A.
|
|
2018
|
159 |
C |
p. 130-133
|
article
|
| 8 |
Impact of immune suppressive agents on the BK-Polyomavirus non coding control region
|
Korth, Johannes
|
|
2018
|
159 |
C |
p. 68-76
|
article
|
| 9 |
Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens
|
Kala, Smriti
|
|
2018
|
159 |
C |
p. 45-54
|
article
|
| 10 |
Inhibition of adenovirus infection by mifepristone
|
Marrugal-Lorenzo, José A.
|
|
2018
|
159 |
C |
p. 77-83
|
article
|
| 11 |
ISAR News
|
|
|
2018
|
159 |
C |
p. e1-e14
|
article
|
| 12 |
Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo
|
Lv, Changjie
|
|
2018
|
159 |
C |
p. 55-62
|
article
|
| 13 |
MERS: Progress on the global response, remaining challenges and the way forward
|
|
|
2018
|
159 |
C |
p. 35-44
|
article
|
| 14 |
Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms
|
Ho, Yi-Jung
|
|
2018
|
159 |
C |
p. 134-142
|
article
|
| 15 |
Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection
|
Khan, Inam Ullah
|
|
2018
|
159 |
C |
p. 95-103
|
article
|
| 16 |
New therapies for human cytomegalovirus infections
|
Britt, William J.
|
|
2018
|
159 |
C |
p. 153-174
|
article
|
| 17 |
Novel cytomegalovirus-inhibitory compounds of the class pyrrolopyridines show a complex pattern of target binding that suggests an unusual mechanism of antiviral activity
|
Hahn, Friedrich
|
|
2018
|
159 |
C |
p. 84-94
|
article
|
| 18 |
Subgenomic flaviviral RNAs: What do we know after the first decade of research
|
Slonchak, Andrii
|
|
2018
|
159 |
C |
p. 13-25
|
article
|
| 19 |
The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice
|
Suschak, John J.
|
|
2018
|
159 |
C |
p. 113-121
|
article
|
| 20 |
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts
|
Mehand, Massinissa Si
|
|
2018
|
159 |
C |
p. 63-67
|
article
|
Journal description